ArticleOncotarget2017
Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.
Taku Fujimura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleOncotarget2017
Taku Fujimura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.